| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | ARM-type_fold | MROH9 PDS5B SAAL1 RTTN SCYL1 RICTOR ITPR1 THADA LTN1 EFR3B CAB39L | 1.82e-06 | 339 | 99 | 11 | IPR016024 |
| Domain | ARM-like | 1.34e-05 | 270 | 99 | 9 | IPR011989 | |
| Domain | - | 2.38e-05 | 222 | 99 | 8 | 1.25.10.10 | |
| Domain | AT_hook | 3.85e-04 | 27 | 99 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 3.85e-04 | 27 | 99 | 3 | IPR017956 | |
| Domain | PAM2 | 9.77e-04 | 9 | 99 | 2 | PF07145 | |
| Domain | Ataxin-2_C | 9.77e-04 | 9 | 99 | 2 | IPR009818 | |
| Domain | Myotubularin-like_Pase_dom | 2.43e-03 | 14 | 99 | 2 | IPR010569 | |
| Domain | PPASE_MYOTUBULARIN | 2.43e-03 | 14 | 99 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 2.43e-03 | 14 | 99 | 2 | IPR030564 | |
| Domain | Myotub-related | 2.43e-03 | 14 | 99 | 2 | PF06602 | |
| Domain | ADH_SHORT | 2.79e-03 | 53 | 99 | 3 | PS00061 | |
| Domain | adh_short | 3.10e-03 | 55 | 99 | 3 | PF00106 | |
| Domain | GRAM | 3.18e-03 | 16 | 99 | 2 | SM00568 | |
| Domain | SDR_fam | 3.27e-03 | 56 | 99 | 3 | IPR002347 | |
| Domain | Apc4_WD40_dom | 4.97e-03 | 20 | 99 | 2 | IPR024977 | |
| Domain | ANAPC4_WD40 | 4.97e-03 | 20 | 99 | 2 | PF12894 | |
| Domain | RCC1 | 4.97e-03 | 20 | 99 | 2 | PF00415 | |
| Domain | C2 | 5.21e-03 | 131 | 99 | 4 | PF00168 | |
| Pubmed | JCAD SAAL1 COPA ENTR1 RICTOR RCC1 FAM171B ERBIN ITPR1 C2CD3 SMG7 GSE1 ATXN2 AHNAK MTM1 SBF2 CCDC138 LTN1 EFR3B UTRN | 4.54e-11 | 1049 | 105 | 20 | 27880917 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDS5B COPA UBE4B TBC1D2 RICTOR RCC1 CHD7 ERBIN PRDM2 GSE1 WDHD1 ZNF644 SENP6 NOP2 CLUH | 1.24e-08 | 774 | 105 | 15 | 15302935 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | PDS5B UBE4B SCYL1 PARP14 ERBIN GSE1 WDHD1 ZNF644 PRKACG NOP2 | 9.11e-08 | 341 | 105 | 10 | 32971831 |
| Pubmed | SAAL1 ASH1L RICTOR CHD7 FAM171B ERBIN PRDM2 ITPR1 WDHD1 SBF2 TET1 LTN1 TMEM131 QSER1 POLK UTRN | 1.65e-07 | 1084 | 105 | 16 | 11544199 | |
| Pubmed | COPA RB1 BICRA ENTR1 TWNK CHD7 ERBIN PRDM2 LDB1 SMG7 GSE1 ATXN2 ZNF644 CCDC138 N4BP1 QSER1 NOP2 MRPL1 | 2.70e-07 | 1429 | 105 | 18 | 35140242 | |
| Pubmed | 1.42e-06 | 263 | 105 | 8 | 34702444 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B COPA UBE4B RB1 POLE RICTOR RCC1 CHD7 ERBIN ZBED5 DECR1 AHNAK LTN1 DDX60L NOP2 UTRN | 3.03e-06 | 1353 | 105 | 16 | 29467282 |
| Pubmed | SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell survival. | 9.03e-06 | 2 | 105 | 2 | 18632617 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 2531080 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 27732084 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 7538672 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 20138207 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12944478 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 18182380 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 9516136 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 10444334 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 33075816 | ||
| Pubmed | RABL2 positively controls localization of GPCRs in mammalian primary cilia. | 9.03e-06 | 2 | 105 | 2 | 30578315 | |
| Pubmed | 9.23e-06 | 242 | 105 | 7 | 34011540 | ||
| Pubmed | POLE ENTR1 TWNK RICTOR RCC1 SPG11 ERBIN ITPR1 THADA ZNF644 CCDC138 EFR3B TMEM131 NOP2 CLUH MRPL1 | 9.92e-06 | 1487 | 105 | 16 | 33957083 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ZCWPW1 COPA RB1 EBF3 POLE TWNK RCC1 LDB1 GSE1 WDHD1 ZNF644 QSER1 | 1.11e-05 | 857 | 105 | 12 | 25609649 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.18e-05 | 351 | 105 | 8 | 38297188 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.61e-05 | 608 | 105 | 10 | 36089195 | |
| Pubmed | 2.53e-05 | 283 | 105 | 7 | 21903422 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 16397580 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 25348716 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 28939775 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 9223517 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 26133275 | ||
| Pubmed | Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus. | 2.70e-05 | 3 | 105 | 2 | 23261299 | |
| Pubmed | Functional Fcgamma receptor polymorphisms are associated with human allergy. | 2.70e-05 | 3 | 105 | 2 | 24586589 | |
| Pubmed | NRMT is an alpha-N-methyltransferase that methylates RCC1 and retinoblastoma protein. | 2.70e-05 | 3 | 105 | 2 | 20668449 | |
| Pubmed | PDS5B EBF3 BAZ2B BICRA RCC1 CHD7 PRDM2 GSE1 ATXN2 PSMG1 ZNF644 QSER1 NOP2 | 2.88e-05 | 1103 | 105 | 13 | 34189442 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B BAZ2B BICRA RCC1 CHD7 ATXN2 AHNAK ZNF644 SENP6 QSER1 NOP2 MRPL1 | 3.19e-05 | 954 | 105 | 12 | 36373674 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.56e-05 | 202 | 105 | 6 | 33005030 | |
| Pubmed | 4.11e-05 | 418 | 105 | 8 | 34709266 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | COPA POLE SCYL1 TWNK FBXL4 ITPR1 DECR1 THADA ATXN2 ZNF644 CCDC138 TMEM131 NOP2 CLUH MRPL1 | 4.36e-05 | 1496 | 105 | 15 | 32877691 |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 18429927 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 12361948 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 11567631 | ||
| Pubmed | 6.01e-05 | 222 | 105 | 6 | 37071664 | ||
| Pubmed | 6.03e-05 | 711 | 105 | 10 | 33022573 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | PDS5B PLK2 UBE4B RB1 HMOX1 GSE1 ATXN2 AHNAK ZNF644 ZNF566 LPGAT1 NOP2 CLUH | 6.97e-05 | 1203 | 105 | 13 | 29180619 |
| Pubmed | 7.76e-05 | 733 | 105 | 10 | 34672954 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 8.03e-05 | 736 | 105 | 10 | 29676528 | |
| Pubmed | 8.66e-05 | 147 | 105 | 5 | 29576527 | ||
| Pubmed | The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer. | 8.97e-05 | 5 | 105 | 2 | 36690626 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 16103111 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 19309690 | ||
| Pubmed | Rabl2 GTP hydrolysis licenses BBSome-mediated export to fine-tune ciliary signaling. | 8.97e-05 | 5 | 105 | 2 | 33241915 | |
| Pubmed | Primordial germ cell DNA demethylation and development require DNA translesion synthesis. | 8.97e-05 | 5 | 105 | 2 | 38702312 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 10866689 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 20439936 | ||
| Pubmed | Copy number, linkage disequilibrium and disease association in the FCGR locus. | 8.97e-05 | 5 | 105 | 2 | 20508037 | |
| Pubmed | SAAL1 COPA RCC1 ERBIN ITPR1 DECR1 THADA LDB1 PSMG1 AHNAK LTN1 DDX60L NOP2 MRPL1 | 1.11e-04 | 1440 | 105 | 14 | 30833792 | |
| Pubmed | PDS5B SCN11A COPA ASH1L TWNK CC2D1B RCC1 SPG11 ERBIN C2CD3 GSPT2 AHNAK CFAP74 POLQ | 1.12e-04 | 1442 | 105 | 14 | 35575683 | |
| Pubmed | 1.18e-04 | 251 | 105 | 6 | 29778605 | ||
| Pubmed | 1.29e-04 | 493 | 105 | 8 | 15368895 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 16029194 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 26903512 | ||
| Pubmed | PtdIns5P regulation through evolution: roles in membrane trafficking? | 1.34e-04 | 6 | 105 | 2 | 18774718 | |
| Pubmed | JCAD PLK2 VWF COPA UBE4B ASH1L ZBED5 LDB1 PSMG1 MTM1 SENP6 TMEM131 UTRN | 1.34e-04 | 1285 | 105 | 13 | 35914814 | |
| Pubmed | 1.52e-04 | 645 | 105 | 9 | 25281560 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | UBE4B SLC38A9 BICRA ASH1L ERBIN THADA LDB1 SMG7 ATXN2 SBF2 CAB39L QSER1 POLK UTRN | 1.57e-04 | 1489 | 105 | 14 | 28611215 |
| Pubmed | 1.66e-04 | 653 | 105 | 9 | 22586326 | ||
| Pubmed | Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. | 1.93e-04 | 37 | 105 | 3 | 24162737 | |
| Pubmed | Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly. | 2.09e-04 | 38 | 105 | 3 | 36674791 | |
| Pubmed | 2.19e-04 | 533 | 105 | 8 | 25544563 | ||
| Pubmed | 2.37e-04 | 99 | 105 | 4 | 19730683 | ||
| Pubmed | Retinoblastoma promotes definitive erythropoiesis by repressing Id2 in fetal liver macrophages. | 2.50e-04 | 8 | 105 | 2 | 15616565 | |
| Pubmed | 2.66e-04 | 102 | 105 | 4 | 11214970 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.86e-04 | 104 | 105 | 4 | 31240132 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 2.90e-04 | 704 | 105 | 9 | 29955894 | |
| Pubmed | 3.21e-04 | 9 | 105 | 2 | 20227374 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 3.38e-04 | 719 | 105 | 9 | 35337019 | |
| Pubmed | 3.43e-04 | 306 | 105 | 6 | 18973680 | ||
| Pubmed | 3.69e-04 | 46 | 105 | 3 | 35022314 | ||
| Pubmed | 4.00e-04 | 10 | 105 | 2 | 19061646 | ||
| Pubmed | BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. | 4.00e-04 | 10 | 105 | 2 | 17576813 | |
| Pubmed | Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. | 4.00e-04 | 10 | 105 | 2 | 8422330 | |
| Pubmed | Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human. | 4.00e-04 | 10 | 105 | 2 | 9736772 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 4.22e-04 | 588 | 105 | 8 | 38580884 | |
| Pubmed | 4.33e-04 | 116 | 105 | 4 | 30804394 | ||
| Pubmed | 4.62e-04 | 118 | 105 | 4 | 30979931 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 5.19e-04 | 462 | 105 | 7 | 31138677 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | UBE4B BICRA POLE RTTN TWNK SLC10A3 THADA C2CD3 AHNAK SBF2 FUT1 | 5.19e-04 | 1105 | 105 | 11 | 35748872 |
| Pubmed | 5.27e-04 | 332 | 105 | 6 | 37433992 | ||
| Pubmed | IL16 RB1 BICRA ENTR1 ASH1L RICTOR THADA SMG7 GSE1 UTP25 LTN1 | 5.63e-04 | 1116 | 105 | 11 | 31753913 | |
| Pubmed | 5.67e-04 | 469 | 105 | 7 | 27634302 | ||
| Pubmed | Amyotrophic lateral sclerosis: an update on recent genetic insights. | 5.84e-04 | 12 | 105 | 2 | 24085347 | |
| Pubmed | Trisomy 21 Alters DNA Methylation in Parent-of-Origin-Dependent and -Independent Manners. | 5.84e-04 | 12 | 105 | 2 | 27100087 | |
| Pubmed | 5.84e-04 | 12 | 105 | 2 | 24291790 | ||
| Pubmed | 5.84e-04 | 12 | 105 | 2 | 30631079 | ||
| Pubmed | The CEP19-RABL2 GTPase Complex Binds IFT-B to Initiate Intraflagellar Transport at the Ciliary Base. | 5.84e-04 | 12 | 105 | 2 | 28625565 | |
| Pubmed | 5.97e-04 | 340 | 105 | 6 | 29478914 | ||
| Pubmed | 6.84e-04 | 230 | 105 | 5 | 35449600 | ||
| Pubmed | 6.89e-04 | 13 | 105 | 2 | 24941225 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 7.78e-04 | 495 | 105 | 7 | 27705803 | |
| Pubmed | 8.02e-04 | 14 | 105 | 2 | 16452507 | ||
| Pubmed | 8.03e-04 | 360 | 105 | 6 | 33111431 | ||
| GeneFamily | DNA polymerases | 8.92e-05 | 23 | 69 | 3 | 535 | |
| GeneFamily | RAB like GTPases | 1.42e-04 | 5 | 69 | 2 | 394 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 1.46e-03 | 15 | 69 | 2 | 903 | |
| GeneFamily | DNA helicases | 1.88e-03 | 17 | 69 | 2 | 1167 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 3.06e-03 | 76 | 69 | 3 | 743 | |
| Coexpression | GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 3.96e-07 | 168 | 105 | 8 | M6874 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B RB1 BAZ2B SPG11 ITPR1 C2CD3 GSE1 WDHD1 ATXN2 LTN1 SERPINB2 CDYL TMEM131 N4BP1 | 8.25e-06 | 856 | 105 | 14 | M4500 |
| Coexpression | JAIN_NFKB_SIGNALING | 1.29e-05 | 75 | 105 | 5 | M17646 | |
| Coexpression | GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 1.54e-05 | 198 | 105 | 7 | M7610 | |
| Coexpression | GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP | 1.59e-05 | 199 | 105 | 7 | M9238 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 1.64e-05 | 200 | 105 | 7 | M291 | |
| Coexpression | GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN | 1.64e-05 | 200 | 105 | 7 | M6789 | |
| Coexpression | ACEVEDO_LIVER_CANCER_DN | 6.35e-05 | 540 | 105 | 10 | M7577 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.58e-08 | 188 | 105 | 8 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.36e-08 | 198 | 105 | 8 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.36e-08 | 198 | 105 | 8 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 1.97e-07 | 175 | 105 | 7 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 1.97e-07 | 175 | 105 | 7 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.67e-07 | 183 | 105 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.86e-07 | 200 | 105 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-06 | 179 | 105 | 6 | b7281160c84dd053a2981c9c76ea6cc6d2592cd5 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-06 | 185 | 105 | 6 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.78e-06 | 189 | 105 | 6 | b5fa3a619e3b554a1a45a551c9b6369075fe5615 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.78e-06 | 189 | 105 | 6 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 6.52e-06 | 193 | 105 | 6 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 7.33e-06 | 197 | 105 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.77e-06 | 199 | 105 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.99e-06 | 200 | 105 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.67e-05 | 148 | 105 | 5 | c240d506151fa90c59f40008c5fb31984c6f6f8f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 4.36e-05 | 164 | 105 | 5 | 346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.02e-05 | 169 | 105 | 5 | f086b50791e1c93e253eb5e8d6c4bf617b1416c3 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.31e-05 | 171 | 105 | 5 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.61e-05 | 173 | 105 | 5 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-05 | 177 | 105 | 5 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-05 | 177 | 105 | 5 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-05 | 177 | 105 | 5 | cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 178 | 105 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 178 | 105 | 5 | 6bef4ef48f649c6e38ae732bc08e6d7814db588b | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.60e-05 | 179 | 105 | 5 | 42f3c040f504a91cc69292d39d22b5715c12526f | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.60e-05 | 179 | 105 | 5 | 063c05753ef1b4a18bc1ebbcae62c8cd25d11070 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.95e-05 | 181 | 105 | 5 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 7.14e-05 | 182 | 105 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.51e-05 | 184 | 105 | 5 | d1ea2b60fb1ca1a0b809d131310c43903a9e84ce | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-05 | 185 | 105 | 5 | 7f46ea82a663181957f88e4e83114aef8a78820c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-05 | 185 | 105 | 5 | 956fb0043c0c3e4e5c4d6f58ff95faf6209c380e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 186 | 105 | 5 | a58c9d1567da0961e0e295a156773d2252ee5a1a | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.11e-05 | 187 | 105 | 5 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | SupraBC-Differ-KC|World / shred by cell class for mouse tongue | 8.53e-05 | 189 | 105 | 5 | 6412741b88e241304033b41effca0c77a374d907 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.53e-05 | 189 | 105 | 5 | 1d660bceee449aebf12fc9af4c74af246837b27a | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 8.53e-05 | 189 | 105 | 5 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.74e-05 | 190 | 105 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.96e-05 | 191 | 105 | 5 | 48cffb55c71bb8b34e926fc461fcd345ce43ea00 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3_mon-IPC_like-IPCs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.96e-05 | 191 | 105 | 5 | e4c1c533771b582e21683dbec6f93a558d865e00 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 9.41e-05 | 193 | 105 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-05 | 193 | 105 | 5 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-05 | 193 | 105 | 5 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 9.41e-05 | 193 | 105 | 5 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.41e-05 | 193 | 105 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-05 | 193 | 105 | 5 | 807fa1443b3c883cb318c71f4fca3c41d58f4910 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 9.41e-05 | 193 | 105 | 5 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.64e-05 | 194 | 105 | 5 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.64e-05 | 194 | 105 | 5 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 9.64e-05 | 194 | 105 | 5 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.64e-05 | 194 | 105 | 5 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-DC-cDC2-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.87e-05 | 195 | 105 | 5 | a2fe352682f548001ca2ee056e7a54af10134453 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.87e-05 | 195 | 105 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.87e-05 | 195 | 105 | 5 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 196 | 105 | 5 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | CV-Moderate-1|Moderate / Virus stimulation, Condition and Cluster | 1.01e-04 | 196 | 105 | 5 | b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.01e-04 | 196 | 105 | 5 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 1.01e-04 | 196 | 105 | 5 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | Mild/Remission|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.01e-04 | 196 | 105 | 5 | 71603a3b7df40eb3f267345f55e44a812fea7926 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 196 | 105 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | CV-Moderate-1|CV / Virus stimulation, Condition and Cluster | 1.04e-04 | 197 | 105 | 5 | e3d00d850b4d191f9592ef993c0eaadfe5710b5f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 197 | 105 | 5 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-04 | 198 | 105 | 5 | cfe2d52b19a1b4c2c2076fa1d5a69baf21a49623 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.06e-04 | 198 | 105 | 5 | d5e125f0c4f41b47d567568d0838adcca7655f6d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 199 | 105 | 5 | bfc157be6e9f84739848eb19b718de5b17f3fa88 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.09e-04 | 199 | 105 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 199 | 105 | 5 | 735e165580136576d39e18060550b57b8c808694 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 199 | 105 | 5 | 9846d6a31635fde759d55674631c11ab9270a603 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-04 | 199 | 105 | 5 | f965eb89d6d023c83154276b8fded490fd89c100 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-04 | 199 | 105 | 5 | 83383d9ae4f501754fd3da0215ce6f0e3c70562c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-04 | 199 | 105 | 5 | 667b8b47a5b388506e3177b46747267fad8024f6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.11e-04 | 200 | 105 | 5 | 3c9e0dc62d14cc00023f7f18053c1a13085d3413 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.11e-04 | 200 | 105 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Neuron|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-04 | 200 | 105 | 5 | a581f1704a87b0390e1e2ff85053367d85247755 | |
| Drug | carmustine; Up 200; 100uM; MCF7; HT_HG-U133A | 2.08e-07 | 192 | 102 | 9 | 6914_UP | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.98e-06 | 197 | 102 | 8 | 3443_DN | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; PC3; HT_HG-U133A | 3.10e-06 | 198 | 102 | 8 | 6347_UP | |
| Drug | tribromoethene | 1.99e-05 | 2 | 102 | 2 | CID000011712 | |
| Drug | 1,2,4-benzenetriol | 2.35e-05 | 76 | 102 | 5 | CID000010787 | |
| Drug | Proglumide [6620-60-6]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.47e-05 | 191 | 102 | 7 | 3861_UP | |
| Drug | L-BVAU | 2.49e-05 | 38 | 102 | 4 | CID000667554 | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.82e-05 | 195 | 102 | 7 | 3705_DN | |
| Drug | 9-aminoacridine | 2.83e-05 | 79 | 102 | 5 | CID000007019 | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 3439_DN | |
| Drug | Benserazide hydrochloride [14919-77-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 3.01e-05 | 197 | 102 | 7 | 5322_DN | |
| Drug | Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; PC3; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 7367_UP | |
| Drug | rotenone; Up 200; 1uM; PC3; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 5920_UP | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 7380_DN | |
| Drug | Epirizole [18694-40-1]; Down 200; 17uM; PC3; HT_HG-U133A | 3.21e-05 | 199 | 102 | 7 | 7292_DN | |
| Disease | malaria (implicated_via_orthology) | 3.13e-06 | 9 | 100 | 3 | DOID:12365 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | IL16 RB1 SERPINF1 TBC1D2 ASH1L CHD7 HMOX1 ITPR1 SULT2B1 SENP6 POLK | 7.93e-06 | 616 | 100 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | IL16 RB1 SERPINF1 TBC1D2 ASH1L CHD7 HMOX1 ITPR1 SULT2B1 SENP6 POLK | 7.93e-06 | 616 | 100 | 11 | C0376358 |
| Disease | lymphocyte count | JCAD PLK2 IL16 SAAL1 UBE4B RB1 SLC38A9 CHD7 ITPR1 THADA ATXN2 AHNAK ZNF644 DDX60L AGBL2 SDR16C5 | 3.24e-05 | 1464 | 100 | 16 | EFO_0004587 |
| Disease | platelet component distribution width | PDS5B JCAD SCN11A ZCWPW1 VWF RTTN GSE1 FCGR2B ATXN2 AGBL2 POLK | 5.13e-05 | 755 | 100 | 11 | EFO_0007984 |
| Disease | retinoblastoma (is_implicated_in) | 6.79e-05 | 4 | 100 | 2 | DOID:768 (is_implicated_in) | |
| Disease | serum gamma-glutamyl transferase measurement | JCAD BICRA ASH1L TWNK ITPR1 FCGR2C THADA GSE1 FCGR2B AHNAK FUT1 | 2.73e-04 | 914 | 100 | 11 | EFO_0004532 |
| Disease | Inherited neuropathies | 3.41e-04 | 40 | 100 | 3 | C0598589 | |
| Disease | alpha fetoprotein measurement | 3.79e-04 | 100 | 100 | 4 | EFO_0010583 | |
| Disease | Mitochondrial DNA Deletion Syndromes | 4.03e-04 | 9 | 100 | 2 | cv:CN043632 | |
| Disease | plexin-B2 measurement | 4.03e-04 | 9 | 100 | 2 | EFO_0021867 | |
| Disease | birth weight | 4.27e-04 | 399 | 100 | 7 | EFO_0004344 | |
| Disease | chronic fatigue syndrome (is_marker_for) | 5.03e-04 | 10 | 100 | 2 | DOID:8544 (is_marker_for) | |
| Disease | end stage renal disease (is_marker_for) | 5.16e-04 | 46 | 100 | 3 | DOID:783 (is_marker_for) | |
| Disease | immature platelet measurement | 7.32e-04 | 119 | 100 | 4 | EFO_0803541 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 7.34e-04 | 12 | 100 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | urate measurement, bone density | 1.23e-03 | 619 | 100 | 8 | EFO_0003923, EFO_0004531 | |
| Disease | Diabetic Angiopathies | 1.32e-03 | 16 | 100 | 2 | C0011875 | |
| Disease | Malaria, susceptibility to | 1.32e-03 | 16 | 100 | 2 | cv:C1970028 | |
| Disease | Microangiopathy, Diabetic | 1.32e-03 | 16 | 100 | 2 | C0025945 | |
| Disease | – | 1.32e-03 | 16 | 100 | 2 | 611162 | |
| Disease | osteosarcoma (is_implicated_in) | 1.32e-03 | 16 | 100 | 2 | DOID:3347 (is_implicated_in) | |
| Disease | cortical thickness | PDS5B CHD7 THADA SMG7 ATXN2 ADAMTS20 TMEM131 QSER1 AGBL2 SDR16C5 CLUH | 1.38e-03 | 1113 | 100 | 11 | EFO_0004840 |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a measurement | 1.50e-03 | 17 | 100 | 2 | EFO_0021969 | |
| Disease | factor VIII measurement, Ischemic stroke | 1.87e-03 | 19 | 100 | 2 | EFO_0004630, HP_0002140 | |
| Disease | acetate measurement | 2.08e-03 | 20 | 100 | 2 | EFO_0010112 | |
| Disease | Malaria | 2.08e-03 | 20 | 100 | 2 | C0024530 | |
| Disease | coagulation factor measurement | 2.08e-03 | 20 | 100 | 2 | EFO_0004634 | |
| Disease | serum carcinoembryonic antigen measurement | 2.08e-03 | 20 | 100 | 2 | EFO_0005760 | |
| Disease | cancer (implicated_via_orthology) | 2.22e-03 | 268 | 100 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | gut microbiome measurement, bone density | 2.39e-03 | 78 | 100 | 3 | EFO_0003923, EFO_0007874 | |
| Disease | Immunologic Deficiency Syndromes | 2.75e-03 | 23 | 100 | 2 | C0021051 | |
| Disease | serum alanine aminotransferase measurement | 2.79e-03 | 869 | 100 | 9 | EFO_0004735 | |
| Disease | malaria (is_implicated_in) | 2.99e-03 | 24 | 100 | 2 | DOID:12365 (is_implicated_in) | |
| Disease | late-onset Alzheimers disease | 3.21e-03 | 292 | 100 | 5 | EFO_1001870 | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-b measurement | 3.24e-03 | 25 | 100 | 2 | EFO_0021970 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FSKSLVSKIFGQPNF | 561 | A8MVM7 | |
| KNQPKLIEFLSSFQK | 296 | Q9H9S4 | |
| KNLPFSFTKLQQLTA | 381 | Q96RT1 | |
| NFTSLFSNKPFLKLG | 671 | Q9NR48 | |
| TAINNLNPAFSKKFV | 66 | Q96FN4 | |
| TNLFLQKPGSFSKLS | 1456 | Q9UIF8 | |
| KLPENFNEAKFITFS | 796 | P41180 | |
| NSPNFEEKKKFLTIF | 856 | Q14687 | |
| FQNGKSKKFSRSDPN | 166 | P31994 | |
| RFKLPKFNFSGSKVQ | 3351 | Q09666 | |
| KNADVLFSSFQKPKQ | 2611 | Q9P2D1 | |
| NFLFNGNFLLSTSKK | 771 | P59510 | |
| FQTQKPLKSTSLSLF | 636 | P06400 | |
| FIPQNLTSFKNSTKS | 281 | P18754 | |
| RFFTQPDKNFSNTKN | 1096 | Q9NTI5 | |
| QSSKKLFIFLGKSLF | 6 | Q8N3Y7 | |
| ASFLDFLKSGPKQQF | 1151 | Q2KHR3 | |
| FLKSGPKQQFSTLAV | 1156 | Q2KHR3 | |
| NPKLDFFKNFLTSLV | 376 | O94822 | |
| TQKSFNFAKKFSLPL | 141 | Q9UBK7 | |
| TQKSFNFAKKFSLPL | 141 | Q9UNT1 | |
| QAFAKKNNLPFLTNV | 196 | Q92604 | |
| NSNSKKKSPASTFAL | 316 | Q86U70 | |
| QPTLKFTNNSKLFPN | 211 | Q8N387 | |
| QRFPFSDKEKNKLTF | 851 | Q14643 | |
| LPKQKEKNTSFRTFS | 1026 | Q86WG5 | |
| DLKKFKNDFRLQPSS | 796 | Q99700 | |
| NSKQLFGQFLLKPVS | 811 | Q9P266 | |
| PAKFQNANLSFSQSK | 1481 | Q5H9U9 | |
| SKSSNLLDLKNPFFR | 461 | Q86X55 | |
| SAFSRKLNVNAKPFV | 46 | Q8IYD1 | |
| FQNGKSKKFSRSDPN | 166 | P31995 | |
| KFSQLLLQVVKPFSF | 346 | P09131 | |
| KPNLQILGTNSFVKF | 111 | Q9Y2G0 | |
| NPKFFGNLQSDDSKK | 666 | Q32MH5 | |
| SDFPFIFNSLSKIKL | 621 | Q8IVU3 | |
| GKLEAQSSNFLFPKA | 116 | Q14005 | |
| SFPENFVFKTTNVKK | 871 | Q07864 | |
| FNKNSLTFSIPPKNK | 621 | Q96RR1 | |
| LFLPKFKSKFQFLVS | 546 | Q5TGP6 | |
| FKSKFQFLVSLPLNV | 551 | Q5TGP6 | |
| DKNSFPFFASSKLVK | 1081 | Q6R327 | |
| SPFLRALKTQNFKDS | 186 | O95456 | |
| LASFLGFSKQSPQKK | 1401 | Q460N5 | |
| TEALQSKFFSPLQKA | 36 | Q16698 | |
| FPFLVKLQFSFKDNS | 101 | P22612 | |
| SADSFKKLPLNLASQ | 2221 | Q4AC94 | |
| NKPKTAAFFKSSNLP | 476 | Q96M89 | |
| LFAASQKFRKNTAPS | 166 | Q9Y232 | |
| FAKLKTQTNASDFPI | 501 | P17927 | |
| FAKLKTQTNASDFPI | 951 | P17927 | |
| LNASFPKVFIKKSFT | 606 | Q9UKA2 | |
| ANPFSFREFLKTKNL | 106 | Q96C92 | |
| RTALNLFFKLKNFKT | 1106 | P53621 | |
| VQTFSQKTKKAPLNF | 1016 | O75417 | |
| PSTAFQVKVKAFNNK | 776 | Q12860 | |
| VKNTNSPEFDQLFKL | 746 | Q5T0F9 | |
| KRVSPISFFLSKFQN | 41 | Q8IZF7 | |
| ASTLQKQPTFFKNSE | 786 | Q5U5Z8 | |
| KQPTFFKNSENSSFL | 791 | Q5U5Z8 | |
| SFASFTSFNPKKFIN | 136 | Q3C1V0 | |
| GLNNATQPKKSISFF | 56 | Q5VTH9 | |
| AKQAKFSTLPRNFSL | 61 | Q5T7N3 | |
| FFTFPNIASATKFKQ | 166 | P09601 | |
| FSFSPANVISAVKQK | 546 | Q9H4W6 | |
| KAFASNLPTLNVAKA | 1036 | Q9NZM4 | |
| LQDPVLKQFKSAFSS | 211 | Q96LJ7 | |
| SKQKCSSAFQNLLPF | 426 | Q96ER3 | |
| PLLNFKSPSFFSKFN | 301 | Q8NBW4 | |
| GFKLQNNSLLPIKFS | 1366 | Q9C0B2 | |
| KLADAKSQPSVQFSK | 186 | Q6P995 | |
| KTSNFNAAISLKFTP | 231 | P02748 | |
| LPSSSFRSKQNVKFA | 1546 | Q13029 | |
| SAAFSKQKLQSAPTK | 376 | Q6UXH9 | |
| FKHLAKASPTQNLFL | 16 | P05120 | |
| ANFTLPDSEFLKIFK | 326 | P19526 | |
| KSNFLQNFLSLALPK | 2051 | Q86VV8 | |
| LGQLFFSSKFQKLET | 221 | Q68CQ4 | |
| EVSTKFQLFQKPANF | 1426 | P46939 | |
| FLQSKTKRKTSNPQF | 196 | Q9BQS2 | |
| KKVLASSLNSLPDFF | 96 | Q6YHU6 | |
| LPIQIFTKAFFSSKA | 126 | O00204 | |
| QKFFQELSKSLDAFP | 291 | Q96KG9 | |
| ESFSPRNFFKTKKQN | 626 | Q5VWT5 | |
| KFPFPAASTNLQKAL | 216 | Q92540 | |
| FLFTTQKNTPLGTKL | 116 | O15466 | |
| IAKFKKFSNSIPQSQ | 581 | P46087 | |
| KSVKNKNSSEFPLFS | 866 | Q13972 | |
| NFFTNPTKNLVSITK | 1401 | Q8NFU7 | |
| LNQISPTFKKNFAVL | 286 | O75153 | |
| NFFLKSKENLFNPSS | 546 | Q96JI7 | |
| LKKFQILDFTSPKQS | 106 | Q9BYD6 | |
| KFKAPQSKALAASFS | 546 | Q9H0M4 | |
| NEFQLQLSPKTFASK | 2066 | P04275 | |
| LINSNKEKFKNPFYT | 501 | Q13496 | |
| FFKVPVNKLAAAVSN | 46 | P36955 | |
| KPLDFSTNQKLSAFA | 1111 | O75717 | |
| SSLSAQFKQNPKEVF | 181 | O95155 | |
| SSSKQFIKKFLSNKP | 126 | Q6ZSR6 | |
| ISFDASKAKKPSQFS | 391 | Q92545 | |
| QSFQTSQPFQVLKKK | 591 | Q9UBT6 | |
| GIKNNISNFFAKIPF | 571 | Q9GZR1 | |
| LFTPFKLLSDSKQFN | 386 | O95427 | |
| FNKSQTSFHLKKPSA | 86 | A0A0B4J244 | |
| FPKNSALKQDVKRTF | 651 | Q9H582 | |
| KFISNSNKITFSKKP | 91 | Q49AG3 | |
| PSFTLQQIINSKKKF | 156 | Q969W8 | |
| QLFGRSFNSQKSPKL | 721 | Q9UI33 | |
| LSSPAKNFFKKAAAA | 356 | Q9NYY3 | |
| KPNFNTNVALKKLAS | 61 | A6NLI5 | |
| KLFLQKRFQSKSFPS | 656 | Q9H8Y1 | |
| AQKAKRQNNTFPFFS | 281 | Q9BYX2 | |
| QFVKLFENKENLPSS | 136 | O75113 |